Reviews - 1uct mentioned but not cited (2)
- Pentraxins and Fc Receptor-Mediated Immune Responses. Lu J, Mold C, Du Clos TW, Sun PD. Front Immunol 9 2607 (2018)
- Targeting Intramembrane Protein-Protein Interactions: Novel Therapeutic Strategy of Millions Years Old. Sigalov AB. Adv Protein Chem Struct Biol 111 61-99 (2018)
Articles - 1uct mentioned but not cited (4)
- Structure of the three N-terminal immunoglobulin domains of the highly immunogenic outer capsid protein from a T4-like bacteriophage. Fokine A, Islam MZ, Zhang Z, Bowman VD, Rao VB, Rossmann MG. J Virol 85 8141-8148 (2011)
- Cells diversify transmembrane signaling through the controlled chaos of protein disorder. Sigalov AB. Self Nonself 2 75-79 (2011)
- The dipeptidyl peptidase IV inhibitors vildagliptin and K-579 inhibit a phospholipase C: a case of promiscuous scaffolds in proteins. Chakraborty S, Rendón-Ramírez A, Ásgeirsson B, Dutta M, Ghosh AS, Oda M, Venkatramani R, Rao BJ, Dandekar AM, Goñi FM. F1000Res 2 286 (2013)
- Identification of therapeutic targets for inflammation in sickle cell disease (SCD) among Indian patients using gene expression data analysis. Das I, Mishra H, Khodiar PK, Patra PK. Bioinformation 14 408-413 (2018)
Reviews citing this publication (7)
- Human antibody-Fc receptor interactions illuminated by crystal structures. Woof JM, Burton DR. Nat Rev Immunol 4 89-99 (2004)
- Mucosal immunoglobulins. Woof JM, Mestecky J. Immunol Rev 206 64-82 (2005)
- The human immunoglobulin A Fc receptor FcαRI: a multifaceted regulator of mucosal immunity. Bakema JE, van Egmond M. Mucosal Immunol 4 612-624 (2011)
- Immunoglobulin A: A next generation of therapeutic antibodies? Bakema JE, van Egmond M. MAbs 3 352-361 (2011)
- Structural analysis of Fc/FcγR complexes: a blueprint for antibody design. Caaveiro JM, Kiyoshi M, Tsumoto K. Immunol Rev 268 201-221 (2015)
- Fc receptors as adaptive immunoreceptors. Daëron M. Curr Top Microbiol Immunol 382 131-164 (2014)
- Fc receptor targeting in the treatment of allergy, autoimmune diseases and cancer. Nakamura A, Akiyama K, Takai T. Expert Opin Ther Targets 9 169-190 (2005)
Articles citing this publication (10)
- KIR2DS4 is a product of gene conversion with KIR3DL2 that introduced specificity for HLA-A*11 while diminishing avidity for HLA-C. Graef T, Moesta AK, Norman PJ, Abi-Rached L, Vago L, Older Aguilar AM, Gleimer M, Hammond JA, Guethlein LA, Bushnell DA, Robinson PJ, Parham P. J Exp Med 206 2557-2572 (2009)
- Fc receptors for immunoglobulins and their appearance during vertebrate evolution. Akula S, Mohammadamin S, Hellman L. PLoS One 9 e96903 (2014)
- Crystal structure of the human natural killer (NK) cell activating receptor NKp46 reveals structural relationship to other leukocyte receptor complex immunoreceptors. Foster CE, Colonna M, Sun PD. J Biol Chem 278 46081-46086 (2003)
- Deglycosylation of FcalphaR at N58 increases its binding to IgA. Xue J, Zhao Q, Zhu L, Zhang W. Glycobiology 20 905-915 (2010)
- FcαRI binding at the IgA1 CH2-CH3 interface induces long-range conformational changes that are transmitted to the hinge region. Posgai MT, Tonddast-Navaei S, Jayasinghe M, Ibrahim GM, Stan G, Herr AB. Proc Natl Acad Sci U S A 115 E8882-E8891 (2018)
- Are single nucleotide polymorphisms of the immunoglobulin A Fc receptor gene associated with allergic asthma? Jasek M, Obojski A, Mańczak M, Wiśniewski A, Winiarska B, Małolepszy J, Jutel M, Łuszczek W, Kuśnierczyk P. Int Arch Allergy Immunol 135 325-331 (2004)
- Discovery of a novel splice variant of Fcar (CD89) unravels sequence segments necessary for efficient secretion: A story of bad signal peptides and good ones that nevertheless do not make it. Lua WH, Ling WL, Su CT, Yeo JY, Verma CS, Eisenhaber B, Eisenhaber F, Gan SK. Cell Cycle 16 457-467 (2017)
- Identification of the linear epitope for Fc-binding on the bovine IgG2 Fc receptor (boFcgamma2R) using synthetic peptides. Zhang G, Guo J, Zhou J, Wang X, Li Q, Yang Y, Shen H, Zhao D, Zhang H, Xi J, Wang L, Qiao S, Jin X. FEBS Lett 580 1383-1390 (2006)
- Increased survival and reduced renal injury in MRL/lpr mice treated with a human Fcγ receptor II (CD32) peptide. Xi J, Zhang GP, Qiao SL, Guo JQ, Wang XN, Yang YY, Zhang LN, Miao XW, Zhao D, Zhi YB, Cai SJ, Luo J, Deng RG. Immunology 136 46-53 (2012)
- Comparative Study The IgA receptor complex: a two-for-one deal. Wurzburg BA, Jardetzky TS. Nat Struct Biol 10 585-587 (2003)